Safety and Efficacy of a Phase 1b Study of Venetoclax Monotherapy or in Combination With Azacitidine for the Treatment of Relapsed/Refractory MDS

96 views
January 23, 2020
0 Comments
Login to view comments. Click here to Login
Hematologic Oncology